Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TEKTURNA HCT | Noden Pharma | N-022107 DISCN | 2008-01-18 | 4 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MODURETIC 5-50 | Merck KGaA | N-018201 DISCN | 1982-01-01 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TRIBENZOR | Cosette Pharmaceuticals | N-200175 RX | 2010-07-23 | 5 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LOTENSIN HCT | Validus Pharmaceuticals | N-020033 RX | 1992-05-19 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ATACAND HCT | ANI PHARMS | N-021093 RX | 2000-09-05 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CAPOZIDE 25/15 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
CAPOZIDE 25/25 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
CAPOZIDE 50/25 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
CAPOZIDE 50/15 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VASERETIC | Bausch Health Companies | N-019221 RX | 1986-10-31 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MONOPRIL-HCT | Bristol Myers Squibb | N-020286 DISCN | 1994-11-30 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TRANDATE HCT | GSK | N-019174 DISCN | 1987-04-10 | 4 products |
NORMOZIDE | Merck Sharp & Dohme | N-019046 DISCN | 1987-04-06 | 4 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZESTORETIC | Almatica Pharma | N-019888 RX | 1989-07-20 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ALDORIL 15 | Merck KGaA | N-013402 DISCN | 1982-01-01 | 1 products |
ALDORIL 25 | Merck KGaA | N-013402 DISCN | 1982-01-01 | 1 products |
ALDORIL D30 | Merck KGaA | N-013402 DISCN | 1982-01-01 | 1 products |
ALDORIL D50 | Merck KGaA | N-013402 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DUTOPROL | Concordia Laboratories | N-021956 DISCN | 2006-08-28 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LOPRESSOR HCT | Validus Pharmaceuticals | N-018303 RX | 1984-12-31 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENICAR HCT | Cosette Pharmaceuticals | N-021532 RX | 2003-06-05 | 3 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INDERIDE LA 80/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE LA 120/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE LA 160/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
INDERIDE-40/25 | WYETH PHARMS INC | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
INDERIDE-80/25 | WYETH PHARMS INC | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
HYDROPRES 25 | Merck KGaA | N-011958 DISCN | 1982-01-01 | 1 products |
HYDROPRES 50 | Merck KGaA | N-011958 DISCN | 1982-01-01 | 1 products |
SERPASIL-ESIDRIX #1 | Novartis | N-011878 DISCN | 1982-01-01 | 1 products |
SERPASIL-ESIDRIX #2 | Novartis | N-011878 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MICARDIS HCT | Boehringer Ingelheim | N-021162 RX | 2000-11-17 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TIMOLIDE 10-25 | Merck KGaA | N-018061 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MAXZIDE-25 | Aurobindo Pharma | N-019129 RX | 1988-05-13 | 1 products, RLD |
MAXZIDE | Aurobindo Pharma | N-019129 RX | 1984-10-22 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
accuretic | New Drug Application | 2023-09-18 |
aldactazide | New Drug Application | 2023-11-23 |
amiloride hydrochloride and hydrochlorothiazide | ANDA | 2023-02-04 |
amlodipine, valsartan and hydrochlorothiazide | ANDA | 2023-12-14 |
amlodipine, valsartan, hydrochlorothiazide | ANDA | 2022-09-30 |
atacand | New Drug Application | 2020-06-19 |
atacand hct | New Drug Application | 2020-05-07 |
avalide | New Drug Application | 2023-07-24 |
benazepril hydrochloride and hydrochlorothiazide | ANDA | 2023-09-30 |
benicar | New Drug Application | 2023-07-12 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Aliskiren Hemifumarate / Hydrochlorothiazide, Tekturna Hct, Noden Pharma | |||
8618172 | 2028-07-13 | DP | |
Amlodipine Besylate / Hydrochlorothiazide / Valsartan, Exforge Hct, Novartis | |||
8101599 | 2023-05-16 | DP | |
8475839 | 2023-05-16 | DP | |
Aliskiren Hemifumarate / Amlodipine Besylate / Hydrochlorothiazide, Amturnide, Novartis | |||
8183295 | 2023-05-16 | DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 69 | 52 | 245 | 282 | 139 | 777 |
Heart failure | D006333 | HP_0001635 | I50 | 4 | 21 | 35 | 56 | 45 | 157 |
Healthy volunteers/patients | — | — | — | 131 | 2 | 1 | 2 | 13 | 149 |
Essential hypertension | D000075222 | — | I10 | 8 | 16 | 46 | 22 | 10 | 99 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 13 | 10 | 13 | 32 | 11 | 75 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 2 | 2 | 10 | 13 | 15 | 41 |
Cardiovascular diseases | D002318 | HP_0001626 | — | 1 | 6 | 15 | 10 | 8 | 39 |
Chronic renal insufficiency | D051436 | — | N18 | 4 | 3 | 3 | 20 | 10 | 38 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | 15 | 2 | 9 | 1 | 3 | 30 |
Coronary artery disease | D003324 | — | I25.1 | 1 | 1 | 2 | 16 | 11 | 30 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypercholesterolemia | D006937 | HP_0003124 | — | — | — | 7 | — | 3 | 10 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 1 | 6 | 3 | — | — | 8 |
Cerebral hemorrhage | D002543 | — | — | — | — | 2 | — | 3 | 5 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 3 | 2 | — | — | 5 |
Aortic valve stenosis | D001024 | HP_0001650 | — | — | 2 | 3 | — | 1 | 5 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | 1 | 1 | — | 1 | 4 |
Heart arrest | D006323 | EFO_0009492 | I46 | — | 1 | 2 | — | 1 | 4 |
Burns | D002056 | — | T30.0 | — | 4 | 4 | — | — | 4 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | 1 | — | 2 | 3 |
Nephrolithiasis | D053040 | — | N20.0 | — | 1 | 2 | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 3 | 1 | — | — | 1 | 5 |
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | 2 | 3 | — | — | — | 4 |
Aging | D000375 | GO_0007568 | R41.81 | — | 1 | — | — | 3 | 4 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 3 | 1 | — | — | — | 4 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 4 | — | — | — | 4 |
Down syndrome | D004314 | EFO_0001064 | Q90 | — | 1 | — | — | 2 | 3 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 2 | — | — | 1 | 3 |
Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | 1 | — | — | 2 | 3 |
Atrial remodeling | D064752 | — | — | — | 1 | — | — | 1 | 2 |
Treatment-resistant schizophrenia | D000090663 | — | — | — | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Morbid obesity | D009767 | EFO_0001074 | — | 1 | — | — | — | 5 | 6 |
Fasting | D005215 | EFO_0002756 | — | 5 | — | — | — | 1 | 6 |
Therapeutic equivalency | D013810 | — | — | 5 | — | — | — | — | 5 |
Vascular stiffness | D059289 | — | — | 1 | — | — | — | 2 | 3 |
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | 2 | 3 |
Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | 2 | 3 |
Crohn disease | D003424 | EFO_0000384 | K50 | 1 | — | — | — | 1 | 2 |
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | — | — | — | 1 | 2 |
Chronic pain | D059350 | HP_0012532 | — | 2 | — | — | — | — | 2 |
Tachycardia | D013610 | HP_0001649 | R00.0 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 3 | 3 |
Anesthesia | D000758 | — | — | — | — | — | — | 3 | 3 |
Hyperaldosteronism | D006929 | HP_0011736 | E26 | — | — | — | — | 2 | 2 |
Headache | D006261 | HP_0002315 | R51 | — | — | — | — | 2 | 2 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 2 | 2 |
Percutaneous coronary intervention | D062645 | — | — | — | — | — | — | 2 | 2 |
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 2 | 2 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | — | — | — | — | 2 | 2 |
Delirium | D003693 | — | R41.0 | — | — | — | — | 2 | 2 |
Trisomy 18 syndrome | D000073842 | — | Q91.3 | — | — | — | — | 2 | 2 |
Drug common name | Hydrochlorothiazide |
INN | hydrochlorothiazide |
Description | Hydrochlorothiazide is a benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. It has a role as a xenobiotic, an environmental contaminant, a diuretic and an antihypertensive agent. It is a benzothiadiazine, a sulfonamide and an organochlorine compound. |
Classification | Small molecule |
Drug class | diuretics (thiazide derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O |
PDB | — |
CAS-ID | 58-93-5 |
RxCUI | — |
ChEMBL ID | CHEMBL435 |
ChEBI ID | 5778 |
PubChem CID | 3639 |
DrugBank | DB00999 |
UNII ID | 0J48LPH2TH (ChemIDplus, GSRS) |